TW..you mean to tell me there are opportunistic lawyers out there chasing the VTA patents? I dont think so. I appreciate your synopsis and others here on the latest verbage in the PR, but in my DD, no one is chasing down PPHM's VTA competitors, as a matter of fact PPHM is the LAST one to get a VTA into humans ... seriously, ADH, OXGN, AZN, MAXM, Antisoma, PDLI, MEDX, ABGX, ViRexx, etx..move ahead, and PPHM sits in 2Q 05 NOW, no patient enrollment in sight for Tarvacin...why?
PPHM is the last..and we should be the front runner....
PPHM the grand master of VTA patents, and they have yet to enroll patients...the grand masters of VTA....and Tarvacin sits...
Go ask SK, Thorpe and David Sherris why?
katie...
News 
Market Data 
Discover 
AI
